Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard Charles Coulon | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
Mike Shippel | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
Stephen M. Martin | M | 77 |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
Geoff Meacham | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
R. Jason Thomas | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jack Arbiser
- Personal Network